ILMN
11
2
VNO
57
5
RSG
77
3
HRB
32
-10
NWL
8
2
LH
42
6
PFG
52
-3
EXR
48
-2
GIS
41
-3
L
39
-2
PCAR
43
3
XRX
34
2
PSX
42
5
BXP
28
-13
MU
54
8
MTCH
57
6
WBA
29
4
ALLE
35
3
NVDA
61
5
MMM
49
2
ILMN
11
2
VNO
57
5
RSG
77
3
HRB
32
-10
NWL
8
2
LH
42
6
PFG
52
-3
EXR
48
-2
GIS
41
-3
L
39
-2
PCAR
43
3
XRX
34
2
PSX
42
5
BXP
28
-13
MU
54
8
MTCH
57
6
WBA
29
4
ALLE
35
3
NVDA
61
5
MMM
49
2
Financhill
Back

Citigroup Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
65

C
Citigroup

Last Price:
$84.59
Seasonality Move:
1.65%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Buy
65
Citigroup (C) is a Buy

Is Citigroup a Buy, Sell or Hold?

  • The current Citigroup [C] share price is $84.61. The Score for C is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • C is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

C Stock Price Chart

What is Citigroup's stock price today?

  • The Citigroup share price today is $84.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and C is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

C Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.01 Buy
Relative Strength Index (14 RSI): 69.38 Buy
Chaikin Money Flow: 15004861 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.85 - 82.95) Buy
Bollinger Bands (100): (63.77 - 77.03) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

C Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.67 Buy
20-day SMA: 81.16 Buy
50-day SMA: 75.53 Buy
200-day SMA: 66.17 Buy
8-day EMA: 81.94 Buy
20-day EMA: 80.26 Buy
50-day EMA: 76.35 Buy
200-day EMA: 67.05 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Citigroup Earnings Growth & C Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.54 per share, an increase this year of $1.52 per share, and an increase next year of $1.79 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Citigroup Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):